(Q44758779)

6 December 2017

title

Treatment of acquired immune deficiency syndrome (AIDS)-related pneumonitis with foscarnet: a double-blind placebo controlled study (English)

1 reference

6 December 2017

1 reference

Youle M

1

1 reference

6 December 2017

Chanas A

series ordinal

2

1 reference

6 December 2017

Gazzard B

series ordinal

3

1 reference

6 December 2017

publication date

1 January 1990

1 reference

6 December 2017

1 reference

6 December 2017

volume

20

1 reference

6 December 2017

issue

1

1 reference

6 December 2017

page(s)

41-50

1 reference

Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition?

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2890%2992302-2

7 January 2021

Cytomegalovirus infections in homosexual men. An epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2890%2992302-2

7 January 2021

Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen fluorescent foci

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2890%2992302-2

7 January 2021

Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2890%2992302-2

7 January 2021

Antiviral effects of phosphonoformate (PFA, foscarnet sodium)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2890%2992302-2

7 January 2021

Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2890%2992302-2

7 January 2021

Treatment of cytomegalovirus pneumonitis with foscarnet (trisodium phosphonoformate) in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2890%2992302-2

7 January 2021

Use of ganciclovir to treat serious cytomegalovirus infections in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2890%2992302-2

7 January 2021

Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2890%2992302-2

7 January 2021

Declining levels of HIV P24 antigen in serum during treatment with foscarnet

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2890%2992302-2

7 January 2021

10.1016/S0163-4453(90)92302-2

Identifiers

DOI

1 reference

6 December 2017

1 reference